Concepedia

Philippe Close

PC

13

Publications

1.2K

Citations

12

H-Index

1993

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Gothenburg

KU Leuven

University of Münster

Philippe Close is an author at Novartis (Switzerland) specializing in hematology, medicine, and thrombosis.

Top concepts

Publications per year

1993–2011

13

Publications

13

A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

Bengt I. Eriksson, Peter Kälebo, Patrick Mouret et al. · New England Journal of Medicine · 1997 · 371 citations · Full text

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

Bengt I. Eriksson, P Kälebo, B Zachrisson et al. · The Lancet · 1996 · 176 citations

, , +13

Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*

Bengt I. Eriksson, Steffan Ekman, Siv Lindbratt et al. · Journal of Bone and Joint Surgery · 1997 · 138 citations

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.

Arjan A. van den Bos, Jaap W. Deckers, Guy R. Heyndrickx et al. · Circulation · 1993 · 113 citations · Full text

Biologic effects of recombinant hirudin (CGP 39393) in human volunteers

Marc Verstraete, J Kienast, Matthias Siebeck et al. · Journal of the American College of Cardiology · 1993 · 70 citations

, , +3

Rows per page

1–5 of 13